wen de yong - Net Worth and Insider Trading

wen de yong Net Worth

The estimated net worth of wen de yong is at least $449,000 dollars as of 2024-06-21. wen de yong is the Directors, senior managers of Shanghai Fosun Pharmaceutical (Group) Co Ltd and owns about 20,000 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) stock worth over $449,000. Details can be seen in wen de yong's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that wen de yong has not made any transactions after 2022-09-08 and currently still holds the listed stock(s).

Transaction Summary of wen de yong

To

wen de yong Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, wen de yong owns 1 companies in total, including Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) .

Click here to see the complete history of wen de yong’s form 4 insider trades.

Insider Ownership Summary of wen de yong

Ticker Comapny Transaction Date Type of Owner
SHSE:600196 Shanghai Fosun Pharmaceutical (Group) Co Ltd 2022-09-08 Directors & senior managers

wen de yong Latest Holdings Summary

wen de yong currently owns a total of 1 stock. wen de yong owns 20,000 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) as of September 8, 2022, with a value of $449,000.

Latest Holdings of wen de yong

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SHSE:600196 Shanghai Fosun Pharmaceutical (Group) Co Ltd 2022-09-08 20,000 22.45 449,000

Holding Weightings of wen de yong


wen de yong Form 4 Trading Tracker

According to the SEC Form 4 filings, wen de yong has made a total of 4 transactions in Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Shanghai Fosun Pharmaceutical (Group) Co Ltd is the acquisition of 10,000 shares on September 8, 2022, which cost wen de yong around $203,000.

Insider Trading History of wen de yong

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

wen de yong Trading Performance

GuruFocus tracks the stock performance after each of wen de yong's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by wen de yong is 3.51%. GuruFocus also compares wen de yong's trading performance to market benchmark return within the same time period. The performance of stocks bought by wen de yong within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how wen de yong's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of wen de yong

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.91 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -6.06 LIMIT LIMIT LIMIT LIMIT LIMIT

wen de yong Ownership Network

Ownership Network List of wen de yong

No Data

Ownership Network Relation of wen de yong

Insider Network Chart

wen de yong Owned Company Details

What does Shanghai Fosun Pharmaceutical (Group) Co Ltd do?

Who are the key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd?

wen de yong is the Directors & senior managers of Shanghai Fosun Pharmaceutical (Group) Co Ltd. Other key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd include senior management bao qin gui , senior management Mei Jing Ping , and senior management li sheng li .

Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Shanghai Fosun Pharmaceutical (Group) Co Ltd Insider Transactions

No Available Data

wen de yong Mailing Address

Above is the net worth, insider trading, and ownership report for wen de yong. Currently GuruFocus does not have mailing address information for wen de yong.

Discussions on wen de yong

No discussions yet.